Dow Up 1.11% Nasdaq Up 1.90%

Alkermes plc (ALKS)

-NasdaqGS
43.19 0.02(0.05%)
Prev Close:43.17
Open:N/A
Bid:43.18 x 200
Ask:43.20 x 200
1y Target Est:50.92
Beta:1.71
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:43.14 - 44.18
52wk Range:34.21 - 54.25
Volume:N/A
Avg Vol (3m):851,098
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-0.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALKS

Comparison

Symbol% ChgMkt Cap
ALKSUp 0.05%N/A
ABTN/A
LLYN/A
GSKN/A

Key Statistics

Forward P/E (1 yr):73.20
P/S (ttm):11.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.27
Quarterly EPS Est (Sep-14) :0.02
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):5.55

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback